On this page
⚠ Educational content only Not medical or genetic advice. Speak with a healthcare provider or genetic counsellor before acting on anything here.

RBL2

RB transcriptional corepressor like 2

Chromosome 16q12.2 HGNC:9894 Tier C
RBL2 16q12.2 p arm q arm 16

RBL2 is located on the long (q) arm of chromosome 16, at band 16q12.2. Arm ratio per GRCh38 - banding schematic.

Explore chromosome 16 in the library →

Available at Jeen Health

Clinical tests that include this

Overview

RBL2 (RB transcriptional corepressor like 2) resides on chromosome 16 and belongs to the retinoblastoma family of cell cycle regulatory proteins. The protein encoded by this gene functions as a transcriptional corepressor, meaning it helps silence specific genes at critical points in the cell cycle. By controlling when certain genes are active, RBL2 contributes to the orderly progression of cell division and helps prevent premature entry into DNA replication phases. Understanding how RBL2 operates provides insight into fundamental mechanisms that maintain cellular organisation and prevent uncontrolled growth.

What the gene does

The RBL2 protein acts primarily as a transcriptional corepressor that regulates genes controlling cell cycle transitions. It binds to specific transcription factors, particularly those in the E2F family, and recruits additional regulatory proteins to block gene expression when cells should remain in a resting state or avoid premature division. This repressive function ensures that cells do not enter S phase (the DNA synthesis stage) until appropriate growth signals and checkpoint controls have been satisfied. Unlike some related proteins, RBL2 may have distinct roles in specific cell types or developmental contexts. The protein's activity is modulated by phosphorylation, which can alter its ability to bind transcription factors and chromatin. Through these mechanisms, RBL2 coordinates cellular responses to growth signals and helps maintain genomic integrity across successive rounds of cell division.

Video: Genetics 101

Chromosome location

RBL2 is located at chromosomal position 16q12.2 on the long arm of chromosome 16. The specific genomic architecture, including the number of exons and regulatory elements, contributes to how the gene is expressed across different tissues and developmental stages.

Protein structure

Domain architecture has not been experimentally characterised in detail for this protein.

Domain map · 1,139 amino acids
Pocket; binds E1A (417-1024)Domain A (417-616)Spacer (617-827)Domain B (828-1024)Pocket; binds E1A417-1024Domain A417-616Spacer617-8271~5701,139
Region - functional region
🧬 Explore 3D structure on AlphaFold
UniProt:Q08999Length:1,139 aaStructure:AlphaFold

Key variants

Genetic variants in RBL2 are documented in clinical databases, though the full spectrum of pathogenic changes remains under investigation. Variants may affect protein stability, binding interactions with transcription factors, or post-translational modification sites. The inheritance pattern for conditions linked to RBL2 variants can vary depending on the specific variant and associated phenotype.

The table below shows the top 7 pathogenic or likely-pathogenic variants currently classified in ClinVar for RBL2.
View all on ClinVar →

Sample of pathogenic variants

7 pathogenic / likely-pathogenic variants from ClinVar, ranked by review status (expert-panel-reviewed first). This is a sample; recurrent founder variants in a specific population may not appear here - see the full ClinVar listing via the link above.

Variant (HGVS) Protein change Classification Evidence Associated condition
c.1179+1_1179+5del
Deletion
- Pathogenic ★☆☆☆ not provided
c.1596_1597del
Microsatellite
p.Leu533fs Pathogenic ★☆☆☆ Brunet-Wagner neurodevelopmental syndrome
c.3085-2_3086del
Deletion
- Pathogenic ★☆☆☆ Brunet-Wagner neurodevelopmental syndrome
c.574C>T
single nucleotide variant
p.Arg192Ter Pathogenic ★☆☆☆ Brunet-Wagner neurodevelopmental syndrome
g.(53498276_53499349)_(53504835_53513065)del
Deletion
- Pathogenic - Brunet-Wagner neurodevelopmental syndrome
c.573-1358_766+5del
Deletion
- Pathogenic - Brunet-Wagner neurodevelopmental syndrome
c.926dup
Duplication
p.Leu310fs Pathogenic - Brunet-Wagner neurodevelopmental syndrome

Evidence stars indicate ClinVar review status. Individual variant interpretation should always be performed by a qualified clinical laboratory - many variants remain classified as Variants of Uncertain Significance (VUS) pending more research.

Associated conditions

At present, no specific inherited conditions have been formally linked to RBL2 variants in widely used clinical databases. Research continues to explore whether alterations in this gene contribute to developmental disorders, cancer predisposition, or other clinical phenotypes. The protein's role in cell cycle control suggests that disruption could theoretically influence processes related to growth regulation.

No condition pages are linked to this gene yet. This does not mean it has no associated conditions.

UK clinical status

Green-listed
High evidence · clinically actionable in NHS testing
Included in NHS GMS signed-off panels

Sources: NHS GMS PanelApp · Genomics England PanelApp · NHS National Genomic Test Directory

Frequently asked questions

What does RBL2 stand for?

RBL2 stands for RB transcriptional corepressor like 2. The name reflects its similarity to the retinoblastoma (RB) protein and its role in repressing gene transcription during cell cycle regulation.

How does RBL2 control the cell cycle?

RBL2 binds to transcription factors such as E2F proteins and prevents them from activating genes required for DNA synthesis. This keeps cells from dividing prematurely until appropriate signals are received.

Are RBL2 variants associated with cancer?

While RBL2 participates in pathways that regulate cell growth, specific inherited cancer syndromes linked to germline RBL2 variants have not been established in clinical databases. Research into its potential role in tumour development continues.

Educational content. This page is not medical or genetic advice, is not individually reviewed by a clinician for each reader, and should not replace a consultation with a qualified healthcare professional or genetic counsellor. If you are considering genetic testing or acting on a test result, book a consultation.
Data sources Last updated 17 April 2026. Content compiled from HGNC · ClinGen · Genomics England PanelApp · NHS National Genomic Test Directory · ClinVar · UniProt · AlphaFold .